- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Lifecare ASA: LIFE Successfully completes the first patient in the longevity trial after three months | 3 | Oslo Børs | ||
| 03.09. | LIFECARE ASA: Extraordinary General Meeting | 2 | Oslo Børs | ||
| 30.08. | Euronext Oslo Børs - Received application for admission to trading - Lifecare ASA | 1 | Oslo Børs | ||
| 30.08. | Correction: LIFE: Lifecare ASA Q2 2024 | - | Oslo Børs | ||
| 27.08. | LIFE: Lifecare ASA Q2 2024 | 3 | Oslo Børs | ||
| 22.08. | Lifecare ASA Q2 2024 presentation | 1 | Oslo Børs | ||
| 13.08. | Lifecare ASA: LIFE: Strategic cooperation to make glucose data more accessible | 3 | Oslo Børs | ||
| 17.07. | Lifecare ASA: LIFE Successfully completed four weeks of longevity trials | 2 | Oslo Børs | ||
| 05.07. | Lifecare ASA: Share capital increase | 2 | Oslo Børs | ||
| 02.07. | Lifecare ASA: Mandatory notification of trade | 2 | Oslo Børs | ||
| 02.07. | Lifecare ASA: LIFE: Cleanroom arrived in Hamburg | 2 | Oslo Børs | ||
| 27.06. | Lifecare ASA: LIFE: Successfully completed first week of longevity trials | 2 | Oslo Børs | ||
| 27.06. | Lifecare ASA: Information about the warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase and warrants registered | 1 | Oslo Børs | ||
| 18.06. | Lifecare ASA: LIFE Longevity trials in dogs starts today | 3 | Oslo Børs | ||
| 14.06. | Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission | 2 | Oslo Børs | ||
| 14.06. | Lifecare ASA: LIFE: Satisfied with the final results of the Rights Issue | 3 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Preliminary results of the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: LIFE Successful in-vitro quality testing of sensor | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Subscription Period in the Rights Issue | 1 | Oslo Børs |
Seite:
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 66,35 | -1,60 % | ROKU Jumps 17.9% in 6 Months: Can Roku Channel Fuel Further Growth? | ||
| SERNOVA | 0,160 | -6,43 % | Sernova Aktie: Kursanstieg und neue Führung | Der Kurs der Sernova Aktie konnte in den letzten Wochen deutlich zulegen. Seit dem Tiefpunkt von 0,13 Euro Ende April hat sich der Wert fast verdoppelt und notiert aktuell bei 0,2155 Euro. Dieser Aufschwung... ► Artikel lesen | |
| PAUL HARTMANN | 198,50 | 0,00 % | EQS-DD: PAUL HARTMANN AG: SCHWENK Limes GmbH & Co. KG, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
19.08.2024 / 15:45... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 74,50 | -1,32 % | Silk Road Medical kurz vor Abschluss der Fusion mit Boston Scientific | ||
| INVIVO THERAPEUTICS HOLDINGS | 0,255 | 0,00 % | NSE - INVIVO THERAPEUTICS HOLDINGS CORP. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| ADDLIFE | 14,350 | +0,49 % | AddLife AB: Interim Report 1 January - 30 June 2024 | Good growth in both Business Areas and continued profitability improvement
"The companies within AddLife showed strong performance development during the quarter. In Labtech, sales growth recovered... ► Artikel lesen | |
| EMBECTA | 14,600 | +0,69 % | Embecta Corp.: embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes | While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin reservoir... ► Artikel lesen | |
| R1 RCM | 12,700 | -0,78 % | R1 RCM Inc. /DE - 8-K, Current Report | ||
| ENOVIS | 38,600 | 0,00 % | Enovis taps former DePuy Synthes executive to lead U.S. Surgical and Global Product and Enabling Technologies business | ||
| SYSMEX | 17,300 | +0,58 % | Dividendenbekanntmachungen (28.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOM CO LTD JP3108600002 6 JPY 0,0366 EUR ADVANEX INC JP3213400009 20 JPY 0,1222 EUR AICA KOGYO CO LTD JP3100800006 59 JPY 0... ► Artikel lesen | |
| PULMONX | 7,400 | +1,37 % | Pulmonx Corporation: Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 | ||
| KANGJI MEDICAL | 0,580 | -1,69 % | KANGJI MEDICAL (09997): NEXT DAY DISCLOSURE RETURN | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO), a leader in comprehensive mental health and wellness... ► Artikel lesen | |
| SI-BONE | 14,000 | +2,19 % | SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System | SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,358 | -60,00 % | PEIJIA-B (09996): NEXT DAY DISCLOSURE RETURN |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +4,70 % bei einem Aktienkurs von 0,138 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.
